New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2014
09:07 EDTSUPNSupernus issued third U.S. patent for Oxtellar XR
Supernus Pharmaceuticals announced the issuance of a third patent by the United States Patent and Trademark Office covering Oxtellar XR, its novel once-daily extended-release oxcarbazepine product. The patent was issued by the USPTO on December 31, 2013. It provides protection for the product with expiration that is no earlier than 2027.
News For SUPN From The Last 14 Days
Check below for free stories on SUPN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 22, 2014
18:18 EDTSUPNOn The Fly: After Hours Movers
Subscribe for More Information
16:21 EDTSUPNSupernus to explore 'broad range of strategic opportunities'
Supernus Pharmaceuticals is providing the following business update in light of recent investor filings with the SEC: "The company will explore a broad range of strategic opportunities. This includes in-licensing products and entering into co-promotion partnerships which are synergistic with our neurology sales force call point, potential co-development partnerships on our pipeline products, and growth opportunities through value-creating and transformative merger and acquisition transactions."
16:20 EDTSUPNSupernus reaffirms it is on track to become cash flow breakeven by year-end
Subscribe for More Information
September 9, 2014
19:00 EDTSUPNOrchard Hill lowers stake in Supernus to 7% from 7.5%, says shares worth $13-$14
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use